✦ LIBER ✦

Endocrinology and pharmacokinetics of oral 4-hydroxyandrostenedione in postmenopausal patients with advanced breast cancer [Poster 26]

✍ Scribed by M. Dowsett; D. Cunningham; S. Nichols; A. Lal; S. Evans; A.M.H. brodle; S.L. Jeffcoate; R.C. Coombes

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

4-HYDROXYANDROSTENEDIONE IN TREATMENT OF

✍ Coombes, R.Charles; Dowsett, Mitch; Goss, Paul; Gazet, J-C.; Brodie, Angela 📂 Article 📅 1984 🏛 The Lancet 🌐 English ⚖ 352 KB

Dose-related endocrine effects of pharma

✍ Dowsett, M; Cunningham, DC; Stein, RC; Evans, S; Dehennin, L; Hedley, A; Coombes 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Treatment of advanced breast cancer in p

✍ Robert C. Stein; Mitchell Dowsett; Anthea Hedley; Joanna Davenport; Jean-Claude 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 372 KB

4-Hydroxyandrostenedione (4-OHA) as firs

✍ Zilembo, N.; Bajetta, E.; Noberasco, C.; Buzzoni, R.; Martinetti, A.; Ferrari, L 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 164 KB

702 - 4-hydroxyandrostenedione (4-OHA) a

✍ C.S. Gennatas; J. Psychogios; C. Dardoufas; N. Tsavaris; S. Athanasiadis 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 215 KB

A randomized study with 4-hydroxyandrost

✍ Bajetta, E.; Zilembo, N.; Buzzoni, R.; Noberasco, C.; Sacchini, V.; La Monica, G 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 155 KB